Journal of General Virology, Vol 78, 23-29, Copyright © 1997 by Society for General Microbiology

ARTICLES

Molecular characterization of virus-specific RNA produced in the brains of flavivirus-susceptible and -resistant mice after challenge with Murray Valley encephalitis virus

N Urosevic, M van Maanen, JP Mansfield, JS Mackenzie and GR Shellam
Department of Microbiology, University of Western Australia, Nedlands. nadia@uniwa.uwa.edu.au

Natural resistance to flaviviruses in mice is controlled by a single genetic locus, FIv, on chromosome 5. Although the mechanism of this resistance is not fully understood, it is believed to operate at the level of virus replication rather than the immune response. It has been hypothesized that enhanced production of viral defective interfering (DI) particles is responsible for a substantial reduction in the titres of infectious virus in resistant mice. However, this has never been established at the molecular level since such particles have not been isolated and characterized. We have studied the products of virus replication in the brains of flavivirus-susceptible C3H/HeJ (Flv(s)) and -resistant congenic C3H/RV (Flv(r)) mice after an intracerebral challenge (i.c.) with Murray Valley encephalitis (MVE) virus and have found no evidence for the accumulation of truncated viral RNA in the brains of resistant mice. All three major viral RNA species, the replicative intermediate (RI), replicative form (RF) and virion RNA (vRNA) together with a subgenomic RNA species of 0.6 kb, which has not been previously described, were present in the brains of both mouse strains. However, the viral RF and RI RNA forms preferentially accumulated in the brains of resistant mice. Thus, we confirm that the resistance allele Flv(r) interferes with discrete steps in flavivirus replication, although the precise mechanism remains to be determined.

This article has been cited by other articles:

				S. V. Scherbik, J. M. Paranjape, B. M. Stockman, R. H. Silverman, and M. A. Brinton RNase L Plays a Role in the Antiviral Response to West Nile Virus J. Virol., March 15, 2006; 80(6): 2987 - 2999. [Abstract] [Full Text] [PDF]

				L. Pantelic, H. Sivakumaran, and N. Urosevic Differential Induction of Antiviral Effects against West Nile Virus in Primary Mouse Macrophages Derived from Flavivirus-Susceptible and Congenic Resistant Mice by Alpha/Beta Interferon and Poly(I-C) J. Virol., February 1, 2005; 79(3): 1753 - 1764. [Abstract] [Full Text] [PDF]

				K.-C. Lin, H.-L. Chang, and R.-Y. Chang Accumulation of a 3'-Terminal Genome Fragment in Japanese Encephalitis Virus-Infected Mammalian and Mosquito Cells J. Virol., May 15, 2004; 78(10): 5133 - 5138. [Abstract] [Full Text] [PDF]

				C. E. Samuel Host genetic variability and West Nile virus susceptibility PNAS, September 3, 2002; 99(18): 11555 - 11557. [Full Text] [PDF]

				T. Mashimo, M. Lucas, D. Simon-Chazottes, M.-P. Frenkiel, X. Montagutelli, P.-E. Ceccaldi, V. Deubel, J.-L. Guenet, and P. Despres A nonsense mutation in the gene encoding 2'-5'-oligoadenylate synthetase/L1 isoform is associated with West Nile virus susceptibility in laboratory mice PNAS, August 20, 2002; 99(17): 11311 - 11316. [Abstract] [Full Text] [PDF]

				A. A. Perelygin, S. V. Scherbik, I. B. Zhulin, B. M. Stockman, Y. Li, and M. A. Brinton Positional cloning of the murine flavivirus resistance gene PNAS, July 9, 2002; 99(14): 9322 - 9327. [Abstract] [Full Text] [PDF]

				O. J. Silvia, G. R. Shellam, and N. Urosevic Innate resistance to flavivirus infection in mice controlled by Flv is nitric oxide-independent J. Gen. Virol., March 1, 2001; 82(3): 603 - 607. [Abstract] [Full Text]

				N Urosevic, O. Silvia, M. Sangster, J. Mansfield, S. Hodgetts, and G. Shellam Development and characterization of new flavivirus-resistant mouse strains bearing Flv(r)-like and Flv(mr) alleles from wild or wild- derived mice J. Gen. Virol., April 1, 1999; 80(4): 897 - 906. [Abstract]

				M. U. Lancaster, S. I. Hodgetts, J. S. Mackenzie, and N. Urosevic Characterization of Defective Viral RNA Produced during Persistent Infection of Vero Cells with Murray Valley Encephalitis Virus J. Virol., March 1, 1998; 72(3): 2474 - 2482. [Abstract] [Full Text] [PDF]